Fangwei Xie

821 total citations
26 papers, 695 citations indexed

About

Fangwei Xie is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Fangwei Xie has authored 26 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Fangwei Xie's work include Cancer Cells and Metastasis (6 papers), Cancer Research and Treatments (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Fangwei Xie is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Cancer Research and Treatments (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Fangwei Xie collaborates with scholars based in China and United States. Fangwei Xie's co-authors include Xuenong Ouyang, Houjie Liang, Lee Jia, Haiyan Dong, Jianfang Chen, Yu Gao, Kun Li, Xiaodong Xie, Yusheng Lu and Jingwei Shao and has published in prestigious journals such as Nature Communications, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Fangwei Xie

25 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangwei Xie China 15 367 265 165 105 67 26 695
Yanfang Huang China 15 361 1.0× 126 0.5× 180 1.1× 109 1.0× 57 0.9× 60 767
Teng Hou China 17 525 1.4× 130 0.5× 319 1.9× 99 0.9× 56 0.8× 41 861
Swati Gupta United States 20 679 1.9× 335 1.3× 130 0.8× 62 0.6× 147 2.2× 45 1.3k
Pu Cheng China 17 253 0.7× 206 0.8× 113 0.7× 105 1.0× 59 0.9× 49 782
Jiayi Qian China 15 530 1.4× 130 0.5× 180 1.1× 114 1.1× 44 0.7× 55 864
Weijun Ou China 15 481 1.3× 168 0.6× 171 1.0× 113 1.1× 39 0.6× 33 891
S. Man Canada 8 366 1.0× 307 1.2× 147 0.9× 83 0.8× 48 0.7× 14 770
Sonia Vivet France 12 356 1.0× 248 0.9× 92 0.6× 68 0.6× 22 0.3× 16 702
Chun‐Mei Hu Taiwan 16 395 1.1× 225 0.8× 160 1.0× 109 1.0× 47 0.7× 48 778
Yen‐An Chen Taiwan 17 351 1.0× 239 0.9× 212 1.3× 35 0.3× 64 1.0× 33 1.0k

Countries citing papers authored by Fangwei Xie

Since Specialization
Citations

This map shows the geographic impact of Fangwei Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangwei Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangwei Xie more than expected).

Fields of papers citing papers by Fangwei Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangwei Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangwei Xie. The network helps show where Fangwei Xie may publish in the future.

Co-authorship network of co-authors of Fangwei Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Fangwei Xie. A scholar is included among the top collaborators of Fangwei Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangwei Xie. Fangwei Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Fangwei, et al.. (2023). 2D-2D heterostructure of ionic liquid-exfoliated MoS2/MXene as lithium polysulfide barrier for Li-S batteries. Journal of Colloid and Interface Science. 636. 528–536. 25 indexed citations
2.
Xie, Fangwei, Chunjie Xu, Yazhou Liang, et al.. (2023). Cubic FeS2 enabling robust polysulfide adsorption and catalysis in lithium/sulfur batteries. Journal of Energy Storage. 72. 108712–108712. 32 indexed citations
3.
Wu, Jingjing, Lijun Zhu, Jing Feng, et al.. (2023). Real-world treatment patterns and survival for locally advanced esophageal squamous cell carcinoma. Medicine. 102(34). e34647–e34647. 3 indexed citations
5.
Xie, Xiaodong, Huifang Nie, Yu Zhou, et al.. (2019). Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles. Nature Communications. 10(1). 5476–5476. 87 indexed citations
6.
Dong, Haiyan, Jie Wang, Jingjing Xie, et al.. (2018). In vivo inhibition of circulating tumor cells by two apoptosis-promoting circular aptamers with enhanced specificity. Journal of Controlled Release. 280. 99–112. 26 indexed citations
7.
Yu, Suhong, Yewei Zhu, Fangwei Xie, et al.. (2015). Systems pharmacology of mifepristone (RU486) reveals its 47 hub targets and network: Comprehensive analysis and pharmacological focus on FAK-Src-Paxillin complex. Scientific Reports. 5(1). 7830–7830. 25 indexed citations
8.
Xie, Jingjing, Haiyan Dong, Hongning Chen, et al.. (2015). Exploring cancer metastasis prevention strategy: interrupting adhesion of cancer cells to vascular endothelia of potential metastatic tissues by antibody-coated nanomaterial. Journal of Nanobiotechnology. 13(1). 9–9. 13 indexed citations
9.
Xie, Fangwei, Xi Chen, Xiong Chen, et al.. (2014). Influence of UGT1A1 gene methylation level in colorectal cancer cells on the sensitivity of the chemotherapy drug CPT-11. Biomedicine & Pharmacotherapy. 68(7). 825–831. 9 indexed citations
11.
Xie, Fangwei, Xi Chen, Xiong Chen, et al.. (2013). Regulation and expression of aberrant methylation on irinotecan metabolic genes CES2, UGT1A1 and GUSB in the in-vitro cultured colorectal cancer cells. Biomedicine & Pharmacotherapy. 68(1). 31–37. 6 indexed citations
12.
Chen, Xi, Han Wang, Xuenong Ouyang, Fangwei Xie, & Jingjing Wu. (2013). Research on drug resistance mechanism of trastuzumab caused by the activation of PI3K/Akt signaling pathway. Współczesna Onkologia. 4(4). 363–369. 8 indexed citations
13.
Li, Jianjun, Fangwei Xie, Jianfang Chen, et al.. (2013). Expression of pim-1 in Tumors, Tumor Stroma and Tumor-Adjacent Mucosa Co-Determines the Prognosis of Colon Cancer Patients. PLoS ONE. 8(10). e76693–e76693. 23 indexed citations
14.
Yang, Ping, Pei Li, Liqiang Zhang, et al.. (2012). Uniaxial stress influence on lattice, band gap and optical properties of n-type ZnO: first-principles calculations. Chinese Physics B. 21(1). 16803–16803. 24 indexed citations
15.
Zhang, Liqiang, Tao Xi, Yanfang Zhao, et al.. (2012). The effect of N-doping on the electronic structure of graphene nanoribbon. International Journal of Materials and Structural Integrity. 6(2/3/4). 220–220. 2 indexed citations
16.
Chen, Keli, Feng Pan, Heng Jiang, et al.. (2011). Highly enriched CD133+CD44+ stem-like cells with CD133+CD44high metastatic subset in HCT116 colon cancer cells. Clinical & Experimental Metastasis. 28(8). 751–763. 88 indexed citations
17.
Ding, Zhenyu, Yang Li, Xiaodong Xie, et al.. (2010). Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells. Journal of Cancer Research and Clinical Oncology. 136(11). 1697–1707. 88 indexed citations
18.
Xie, Fangwei, Kun Li, & Xuenong Ouyang. (2009). Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients. Clinical & Experimental Metastasis. 26(8). 1025–1032. 47 indexed citations
19.
Chen, Jianfang, Fangwei Xie, Keli Chen, et al.. (2009). ERCC5 promoter polymorphisms at –763 and +25 predict the response to oxaliplatin-based chemotherapy in patients with advanced colorectal cancer. Cancer Biology & Therapy. 8(14). 1424–1430. 30 indexed citations
20.
Xie, Fangwei. (2006). Reverse effects of salidroside on expression of c-myc in SMMC-7721 cell line in vitro. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026